| P2093 | author name string | Elana Godebu | |
| | Bas J G Baaten | |
| | Linda M Bradley | |
| | Melissa M Lin | |
| | Daphne Summers-Torres | |
| P2860 | cites work | TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes | Q47667692 |
| | Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells. | Q51103369 |
| | Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells. | Q53859655 |
| | Following a diabetogenic T cell from genesis through pathogenesis | Q70488192 |
| | IL-10 and TGF-beta induce alloreactive CD4+CD25- T cells to acquire regulatory cell function | Q73062421 |
| | Origin of regulatory T cells with known specificity for antigen | Q74381747 |
| | CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2 | Q74660381 |
| | Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals | Q77704341 |
| | A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-beta | Q80427911 |
| | Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10 | Q80785928 |
| | Adaptive islet-specific regulatory CD4 T cells control autoimmune diabetes and mediate the disappearance of pathogenic Th1 cells in vivo | Q83059341 |
| | Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 | Q24672849 |
| | The inhibitory cytokine IL-35 contributes to regulatory T-cell function | Q28258462 |
| | Regulatory T cell lineage specification by the forkhead transcription factor foxp3 | Q28510328 |
| | Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7 | Q28591451 |
| | Making regulatory T cells with defined antigen specificity: role in autoimmunity and cancer | Q29014531 |
| | A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism | Q29614266 |
| | Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid | Q29615586 |
| | Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid | Q29619479 |
| | Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice | Q30644510 |
| | Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs | Q34546789 |
| | Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis | Q34719541 |
| | Enteroviruses and type 1 diabetes mellitus. | Q35598941 |
| | Dendritic cells with TGF-beta1 differentiate naive CD4+CD25- T cells into islet-protective Foxp3+ regulatory T cells | Q35669757 |
| | Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease | Q35703559 |
| | Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment | Q35748567 |
| | The NOD mouse: a model of immune dysregulation | Q36072434 |
| | Mechanisms of suppression by suppressor T cells | Q36078047 |
| | Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice | Q36228938 |
| | Costimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4 cell expansion and Th2 cytokine secretion in vivo | Q36370731 |
| | Interleukin 7 regulates the survival and generation of memory CD4 cells | Q36371578 |
| | Instruction of Treg commitment in peripheral T cells is suited to reverse autoimmunity | Q36394540 |
| | In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes | Q36399048 |
| | CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. | Q36399104 |
| | Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization | Q36402763 |
| | Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. | Q36891917 |
| | The Foxp3+ regulatory T cell: a jack of all trades, master of regulation | Q37088900 |
| | Turnover of naive- and memory-phenotype T cells | Q41475935 |
| | Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. | Q44729936 |
| | Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry | Q45754853 |
| | Induction of tolerance in type 1 diabetes via both CD4+CD25+ T regulatory cells and T regulatory type 1 cells | Q45858705 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | type-1 diabetes | Q124407 |
| P304 | page(s) | 1798-1805 | |
| P577 | publication date | 2008-08-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Polyclonal adaptive regulatory CD4 cells that can reverse type I diabetes become oligoclonal long-term protective memory cells | |
| P478 | volume | 181 | |